DrElena De Vita
Department of Chemistry - Faculty of Natural Sciences
Orcid identifier0000-0003-4707-8342 (opens in a new tab)
- Department of Chemistry - Faculty of Natural Sciences
- Molecular Sciences Research Hub, White City Campus, United Kingdom
RESEARCH
Research Experience
Marie Skłodowska-Curie Fellow (01/08/2020 – PRESENT) – Imperial College London, London, United Kingdom
BBSRC Flexible Talent Mobility Account (01/01 – 31/03/2022) – Imperial College London/MSD, London, United Kingdom
CRUK Research Associate in Medicinal Chemistry (07/01/2019 – 31/07/2020) – Imperial College London, London, United Kingdom
PhD student (04/02/2015 – 28/12/2018) – German Cancer Research Center (DKFZ), Heidelberg, Germany
Visiting scientist in the Tate group (07/01 – 18/03/2018) – Imperial College London, London, United Kingdom
Visiting scientist at PEPCF (01/02 – 01/04/2016) – EMBL, Heidelberg, Germany
M.Sc in Pharmaceutical Chemistry and Technologies [B.Sc M.Sc equivalent] (01/10/2009 – 14/10/2014) – Department of Pharmacy, University of Pisa, Pisa, Italy
GRANTS
BBSRC Flexible Talent Mobility Account01/01/2022 – 31/03/2022 – Imperial College London/MSD, London, United KingdomThis is a BBSRC awarded internal scheme at Imperial College to promote the development of early-career scientists sponsoring secondments with industrial exchange.
Co-Investigator for the project “Covalent small molecules targeting Rab27 to block cancer metastasis” funded by Worldwide Cancer Research (22-0170)01/03/2022 – 01/03/2025 – Imperial College London, London, United KingdomThis is an international yearly-awarded grant to support cancer research. Our proposal is based on the current data generated in my main project and has received very positive feedback from reviewers.
Marie Skłodowska-Curie Fellowship (H2020 MSCA-IF 890900, RabTarget4Metastasis)01/08/2020 – 01/08/2022 – Imperial College London, London, United KingdomThis is a competitive fellowship granted from the European Commission to support my research.
EMBO short term fellowship (STF-7471)15/01/2019 – European Molecular Biology Organization (EMBO)Fellowship to support a 2-month research visit to the laboratory of Prof Tate at Imperial College London. Project: validation of activity-based probes (ABPs) for Kallikrein-related peptidase 6 (KLK6).
AWARDS
Highly Commended Candidate for L’Oréal-UNESCO For Women in Science UK & Ireland Programme 2022 24/05/2022 – London, United KingdomMy proposal on dephosphorylating chimeras was ranked in the top 10 candidates nationwide, receiving significant media coverage.
Winner of the 2021 Merck Innovation Cup, Prize: € 20,000.0002/07/2021 – Merck KGaA, Darmstadt, GermanyAs part of the Drug Discovery Technologies team, I contributed to develop an initial scientific idea on molecular glues into a structured pitch for innovative applications in Drug Discovery, awarded first place in the Cup.
GDCh Doctoral prize for Medicinal Chemistry, Prize: € 500.0027/03/2019 – Gesellschaft Deutscher Chemiker (GDCh), GermanyAwardee of the Medicinal Chemistry Doctoral Prize (Promotionspreise Medizinische Chemie).
Excellence award14/10/2014 – University of Pisa, ItalyGranted upon successful completion of a merit-based parallel course to promote development of high-profile students. Eligibility: timely graduation with an average score of 27/30 or above, and no grade below 25/30, plus extracurricular courses and examinations.
MEMBERSHIPS
Member of the Royal Society of Chemistry23/02/2022– PRESENT – Royal Society of Chemistry, United Kingdom
Panel Member of the Chemical Biology and Healthcare seminar series 01/07/2021– PRESENT – Imperial College London, United Kingdom
Early-Career Researcher Taskforce 17/12/2020– PRESENT – Biochemical Society/Portland Press, United Kingdom
Early Career Member of the Biochemical Society 01/04/2020– PRESENT – Biochemical Society, United Kingdom
Early Career Panel Member12/02/2020– PRESENT – Future Medicinal Chemistry Journal, United Kingdom
Marie Skłodowska-Curie Fellow (01/08/2020 – PRESENT) – Imperial College London, London, United Kingdom
BBSRC Flexible Talent Mobility Account (01/01 – 31/03/2022) – Imperial College London/MSD, London, United Kingdom
CRUK Research Associate in Medicinal Chemistry (07/01/2019 – 31/07/2020) – Imperial College London, London, United Kingdom
PhD student (04/02/2015 – 28/12/2018) – German Cancer Research Center (DKFZ), Heidelberg, Germany
Visiting scientist in the Tate group (07/01 – 18/03/2018) – Imperial College London, London, United Kingdom
Visiting scientist at PEPCF (01/02 – 01/04/2016) – EMBL, Heidelberg, Germany
M.Sc in Pharmaceutical Chemistry and Technologies [B.Sc M.Sc equivalent] (01/10/2009 – 14/10/2014) – Department of Pharmacy, University of Pisa, Pisa, Italy
GRANTS
BBSRC Flexible Talent Mobility Account01/01/2022 – 31/03/2022 – Imperial College London/MSD, London, United KingdomThis is a BBSRC awarded internal scheme at Imperial College to promote the development of early-career scientists sponsoring secondments with industrial exchange.
Co-Investigator for the project “Covalent small molecules targeting Rab27 to block cancer metastasis” funded by Worldwide Cancer Research (22-0170)01/03/2022 – 01/03/2025 – Imperial College London, London, United KingdomThis is an international yearly-awarded grant to support cancer research. Our proposal is based on the current data generated in my main project and has received very positive feedback from reviewers.
Marie Skłodowska-Curie Fellowship (H2020 MSCA-IF 890900, RabTarget4Metastasis)01/08/2020 – 01/08/2022 – Imperial College London, London, United KingdomThis is a competitive fellowship granted from the European Commission to support my research.
EMBO short term fellowship (STF-7471)15/01/2019 – European Molecular Biology Organization (EMBO)Fellowship to support a 2-month research visit to the laboratory of Prof Tate at Imperial College London. Project: validation of activity-based probes (ABPs) for Kallikrein-related peptidase 6 (KLK6).
AWARDS
Highly Commended Candidate for L’Oréal-UNESCO For Women in Science UK & Ireland Programme 2022 24/05/2022 – London, United KingdomMy proposal on dephosphorylating chimeras was ranked in the top 10 candidates nationwide, receiving significant media coverage.
Winner of the 2021 Merck Innovation Cup, Prize: € 20,000.0002/07/2021 – Merck KGaA, Darmstadt, GermanyAs part of the Drug Discovery Technologies team, I contributed to develop an initial scientific idea on molecular glues into a structured pitch for innovative applications in Drug Discovery, awarded first place in the Cup.
GDCh Doctoral prize for Medicinal Chemistry, Prize: € 500.0027/03/2019 – Gesellschaft Deutscher Chemiker (GDCh), GermanyAwardee of the Medicinal Chemistry Doctoral Prize (Promotionspreise Medizinische Chemie).
Excellence award14/10/2014 – University of Pisa, ItalyGranted upon successful completion of a merit-based parallel course to promote development of high-profile students. Eligibility: timely graduation with an average score of 27/30 or above, and no grade below 25/30, plus extracurricular courses and examinations.
MEMBERSHIPS
Member of the Royal Society of Chemistry23/02/2022– PRESENT – Royal Society of Chemistry, United Kingdom
Panel Member of the Chemical Biology and Healthcare seminar series 01/07/2021– PRESENT – Imperial College London, United Kingdom
Early-Career Researcher Taskforce 17/12/2020– PRESENT – Biochemical Society/Portland Press, United Kingdom
Early Career Member of the Biochemical Society 01/04/2020– PRESENT – Biochemical Society, United Kingdom
Early Career Panel Member12/02/2020– PRESENT – Future Medicinal Chemistry Journal, United Kingdom